Peripherally Inserted Central Catheters Market Size Share Trends Forecast 2027


Posted November 26, 2020 by SANJAYCMI

Peripherally Inserted Central Catheters Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
Peripherally inserted central catheters are used to gain intravenous access that can be for a prolonged period of time. A peripherally inserted central catheters is commonly recommended for cancer treatments, liquid nutrition, and infection treatments.

Statistics:

The global Peripherally Inserted Central Catheters Market is estimated to account for US$ 1,256.1 Mn in terms of value by the end of 2027.

Global Peripherally Inserted Central Catheters Market: Drivers

Approval and launch of new products is expected to propel growth of the global peripherally inserted central catheters market over the forecast period. For instance, in March 2020, Access Vascular received the U.S. Food and Drug Administration clearance for its second-generation HydroPICC peripherally inserted central catheter.

Global Peripherally Inserted Central Catheters Market: Opportunities

Increasing preterm birth-rate is expected to offer lucrative growth opportunities for players in the global peripherally inserted central catheters market. For instance, According to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/peripherally-inserted-central-catheters-market-4048

Global Peripherally Inserted Central Catheters Market: Restraints


Peripherally inserted central catheters, despite their wide use, can lead to local and systemic complications. One of the most crucial complication is deep vein thrombosis, which can lead to pulmonary embolism. Such scenario is expected to hinder growth of the global peripherally inserted central catheters market.

Key Takeaways:

The global peripherally inserted central catheters market was valued at US$ 782.1 Mn in 2019 and is forecast to reach a value of US$ 1,256.1 Mn by 2027 at a CAGR of 6.2% between 2020 and 2027. Increasing approval and launch of new products is expected to propel growth of the global peripherally inserted central catheters market over the forecast period.

Multiple Lumen segment held dominant position in the global peripherally inserted central catheters market in 2019, accounting for 60.8% share in terms of value, the growth of the segment is attributed to increasing incidence and prevalence of chronic diseases such as cancer in developed and developing economies during the forecasted period.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/4048

Market Trends

R&D in peripherally inserted central catheters is expected to boost growth of the global peripherally inserted central catheters market. For instance, in October 2019, researchers from Hartford Hospital (Hartford, Conn.) and PICC Excellence reported that implementing standardized set of best practices for inserting peripheral IV catheters results in significant clinical and economic benefits, in the Journal of the Association for Vascular Access.

Major players in the global peripherally inserted central catheters market are focused on raising funds to expand their product portfolio. For instance, in September 2019, Access Vascular raised US$ 6 million from new and existing investors for the HyrdoPICC device it developed.

Global Peripherally Inserted Central Catheters Market: Competitive Landscape

Major players operating in the global peripherally inserted central catheters market include, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, Argon Medical Devices, Inc., Boston Scientific Corporation, Cook Medical Inc., ICU Medical Inc., Medical Components, Inc., Access Vascular, Medtronic, Inc., and Navilyst Medical, Inc.

Global Peripherally Inserted Central Catheters Market: Key Developments

October 2019: AngioDynamics signed a US$ 66 million deal to acquire Eximo Medical, which includes US$ 46 million upfront plus up to an additional US$ 20 million in technical and sales-based milestones

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4048

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags peripherally inserted central catheters , peripherally inserted central catheters market share , peripherally inserted central catheters market size
Last Updated November 26, 2020